CV Science

Caterina Casari PhD Biochemistry, Molecular Biology, Biotechnology

Course and current status

Education & Training

• December 8^th, 2022 HDR (French accreditation to supervise research/Habilitation à diriger des recherches), University of Paris-Saclay, France
• March 8^th, 2010: PhD Biochemistry, Molecular Biology, Biotechnology, University of Ferrara, Italy
• March 2006: Biomolecular and Cellular Science Master Diploma, University of Ferrara, Italy
• March 2004: Bachelor diploma in Biological Sciences, University of Ferrara, Italy

Professional certifications

• May 2013 Official EU certification for Animal handling 2010/63/EU, France

• June 2010 Professional Italian practice examination for Biology licence, Italy

Research experience

• December 2018-now: Tenured researcher CRCN INSERM UMR-S1176, Le Kremlin-Bicetre, France
• December 2016-November 2018: Research Fellowship INSERM UMR-S1176, Le Kremlin-Bicêtre, France; Advisor: Dr. Cécile V. Denis
• January 2014-August 2016: Postdoctoral Research Associate McAllister Heart Institute, University of North Carolina at Chapel Hill, NC, USA Advisor: Dr. Wolfgang Bergmeier
• August 2010-December 2013: Postdoctoral Research Fellowship INSERM-U770, Le Kremlin-Bicêtre, France Advisor: Dr. Cécile V. Denis
• February-July 2010: Postdoctoral Fellowship University of Ferrara, Italy Advisor:  Prof. Francesco Bernardi
• March 2013: Short-stay Visiting Kyoto University, Japan Dr. Prevost’s Lab
• June 2009: Short-stay Visiting Catholic University Med School, Rome, Prof. De Cristofaro’s Lab

Grants

• July 2023: Project “Technics 2023” of the Graduate School Health and Drug Science, University Paris-Saclay (Equipment, Obtained as PI)
• May 2020: CSL-Behring (France) “Fonds de dotation” for research in hemostasis (Bench fees, Obtained as PI)
• 2014-2016: EHA (European Hematology Association) 3-year Non-Clinical Junior Research Fellowship. (Salary and bench fees, Obtained as PI)
• June 2013: ITMO-IHP (Instituts Thématiques Multi-organismes Immunologie, Hématologie et Pneumologie) French Grant on Thrombosis and Hemostasis as principal investigator, in the framework of a French-Italian collaboration. (Bench fees, Obtained as PI)
• 201-2013: FRM (Fondation pour la Recherche Médicale en France) 2-year Postdoctoral fellowship (Salary)
• March-July 2010: Telethon Foundation, University of Ferrara, Postdoctoral fellowship, Dept. of Biochemistry and Molecular Biology, Italy (Salary).
• June-November 2006: PRIN (Progetti di rilevante interesse nazionale), University of Ferrara, Student fellowship, Dept. of Biochemistry and Molecular Biology, Italy (Salary).

Professional activities

• Membership: ISTH (2013-now) (member of the Media-Based Learning Subcommittee 2023-24, vice-chair 2024-26, member of the Educational Core Committee 2024-26); French Society of T&H (SFTH) (2021-now); European Hematology Association (EHA) (2013-16)
• Past member: ISTH-Early Career Committee 2013-22, chair (2020-22), vice-chair (2018-20); ISTH-Publications Committee 2018-20
• Organization: 2025 ECTH European Congress on T&H (chair Junior Advisory board) (2024-25)
• Organization: 2023 CFH French Conference of T&H (2022-23)
• Organization: Trainee Session (150 participants and ~30 invited speakers), Early Career Lounge & Community Chats at ISTH Congresses (2019, 2020, 2021,2022)
• Organization/moderator or speaker: educational & career development webinars/round tables for ISTH members (2017-23 both in-person and on-line)
• International Advisor/Academic board: Ph.D. Program “Medical, Omic & Oncologic Sciences”, University of Ferrara, Italy (2019-now)

Societal activities with patient associations

• Invited speaker at national/international meetings organized by Patients’ Associations: EHC (European Haemophilia Consortium) (Annual meeting 2021 virtual; New technologies in rare bleeding disorders Workshop 2024 Cascais, Portugal); AFH (French Haemophilia Association) (Annual meeting 2024, Tours, France), Local meeting of Emilia Romagna Haemophilia & Coagulation Disorder Associations and Lions Club International (Ferrara, Italy 2020)
• Invited article for EX journal (Ravenna/Italian Association of Hemophilic/Thalassemic Patients) 2023
• Organization/speaker Annual meetings between patients and researchers. In collaboration with AFH (French Haemophilia Association). (Le Kremlin- Bicêtre, France 2017-18-19)

Conferences & Meetings

• 13 invited lectures at national and international conferences (2019-2024) (including a State-of-the-Art (2023) and two SSC (2021 & 24) presentations at ISTH congresses; plenary lectures at the annual congresses of the national T&H societies of Italy (2020), France (2019-2023), Japan (2024); lectures at BIC 2021 & 2023; EAHAD 2023; ASH 2023; GRC Hemostasis 2024; BRAIN 2024)
• 4 invited lectures at national & international conferences of patients’ associations (ECTH 2021; 2x ECTH international workshop 2023; AFH 2024)
• 8 invited lectures at national & international educational meetings (2016-2024)
• 4 invited lectures at career development sessions (2021-2024)
• 13 selected oral presentations (2009-2022)
• 10 selected poster presentations (2008-2022)
• 9 chair/moderator of scientific sessions (2017-2024)

Awards & Honours

• Travel Award, GRC Hemostasis, Waterville Valley (NH), USA (2024)
• Young Investigator Award, XXX ISTH, London, UK (2022)
• Young Investigator Award, XXV ISTH, Toronto, Canada (2015)
• Best oral presentation at the GRS in Hemostasis, Waterville Valley (NH), USA (2014)
• Trainee Travel Award, THSNA, Chicago (IL), USA (2014)
• Young Investigator Award, XXIV ISTH, Amsterdam, The Netherlands (2013)
• Best Ph.D. thesis Medicine/Biology research area IUSS (University Institute for Superior Study), University of Ferrara, Italy (2011)
• Young Investigator Award, XXII ISTH, Boston (MA), USA (2009)

Teaching Experience

• 2020-2025: University Paris Saclay, Master 2 Biology applied to therapeutic and diagnostic innovation, 1-hour class/year (in French);
• 2020-2021 University Paris Saclay, (2020-21) International Master 1 Development of drugs and health products, 3-hour class/year (in English)
• 2016: University of Ferrara, Italy, Master 2 Environmental and Health Biotechnology, 12-hour short-course on “von Willebrand Factor and Disease” (in English)
• 2006-2010: University of Ferrara, Italy, Master 1 Molecular Biology, Master 2 Clinical Molecular Biology, 2/4-hour/year (in Italian)
• 2006-2008: University of Ferrara, Italy, Molecular Biology laboratory practical activities for undergraduate students, (in Italian).

Editorial Board Membership

• Research and Practice in Thrombosis and Haemostasis (RPTH) (2020-now)
• Journal of Thrombosis and Haemostasis (JTH) (2021-2023)
• Revue Francophone d'Hémostase et Thrombose (RFHT) (2019-now)
• Bleeding Thrombosis and Vascular Biology (BTVB) (2021-now)

Peer-reviewing Platelets, Thrombosis and Haemostasis, Thrombosis Research, Therapeutic Advances in Hematology, Cellular Signaling, Journal of Thrombosis and Haemostasis, Blood Advances, Blood, Research and Practice in Thrombosis and Haemostasis, Scientific Reports

Evaluation of research projects

• Reviewer for ISTH & EHA-ISTH Research Grants (2019-2020-2024-2025)
• Expert Reviewer for Fondazione Cariplo (Italy) “Biomedical research grants for young researchers” (2022)
• External Reviewer for EHA (European Hematology Association) Research Grants (2017)

Evaluation of Ph.D. Thesis

• Experimental & Translational Medicine, University Cattolica del Sacro Cuore, Roma, Italy (2023) 
• Molecular and cellular biology, University of Antilles, France (2022)
• Biomedical Sciences & Biotechnology, University of Ferrara, Italy (2018)
• MEMBER OF THREE PhD COMMITTEES (CSI-France)

• International PhD evaluation: PhD Program “Translational Medicine”, University of Milan, Italy (2022)

Evaluation of congress abstracts: ISTH 2020 to 2025; ASH 2022; CFH 2023; BIC 2025

Member of 3 Selection Committees for MCF (Maître de conference) (2021-2022)

Scientific summary

Caterina is a tenured researcher at Inserm U1176. Her research studies are focused on von Willebrand factor (VWF) and his partners. She is interested in developing in vitro & in vivo models to elucidate molecular mechanisms underlying unsolved clinical aspects of congenital and acquired von Willebrand disease (VWD). She is also interested in exploring new molecular strategies that can be applied as therapeutic approaches for VWF-associated disorders.